
Co-Diagnostics (CODX) Market Capitalization Overview
Market Cap: $12.97M as of Jan 9, 2026
$12.97M
$3.81M (22.68%)past month
As of Jan 9, 2026, Co-Diagnostics (CODX) has a market capitalization of $12.97M. Over the past 30 days, its market cap has decreased by -48.72%, while in the last 12 months, it has increased by 59.77%.
Market capitalization represents the total value of Co-Diagnostics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
Co-Diagnostics (CODX) Market Cap Formula = Stock Price * Shares Outstanding
The market cap of Co-Diagnostics (CODX) helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of Co-Diagnostics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
Co-Diagnostics (CODX) Market Cap Formula = Stock Price * Shares Outstanding
The market cap of Co-Diagnostics (CODX) helps investors assess the company's size and compare it with competitors for better investment decisions.
Co-Diagnostics (CODX) Market Cap & Key Trends
See Co-Diagnostics’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in Co-Diagnostics (CODX)
Order type
Buy in
Order amount
Est. shares
0 shares
Co-Diagnostics (CODX) Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| Dec 1, 2025 | $17.40M | -10.57% |
| Nov 3, 2025 | $19.46M | +14.44% |
| Oct 1, 2025 | $16.99M | +46.77% |
| Sep 2, 2025 | $11.59M | +28.97% |
| Aug 1, 2025 | $8.99M | -10.72% |
| Jul 1, 2025 | $10.06M | +14.70% |
| Jun 2, 2025 | $8.77M | -28.42% |
| May 1, 2025 | $12.26M | +11.32% |
| Apr 1, 2025 | $11.01M | -30.36% |
| Mar 3, 2025 | $15.81M | -34.95% |
| Feb 3, 2025 | $24.30M | +1.72% |
| Jan 2, 2025 | $23.89M | -20.19% |
Co-Diagnostics (CODX) End of Year Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| 2026 | $12.97M | +59.77% |
| 2025 | $8.12M | -67.26% |
| 2024 | $24.80M | -39.20% |
| 2023 | $40.78M | -47.66% |
| 2022 | $77.92M | -74.20% |
| 2021 | $302.02M | — |
FAQs About Co-Diagnostics (CODX) Market Cap
As of Jan 9, 2026, the market capitalization of Co-Diagnostics (CODX) is $12.97M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, Co-Diagnostics’s market capitalization has decreased by -22.68%, changing from $16.78M to $12.97M as of Jan 9, 2026.
In the last 3 months, Co-Diagnostics’s market capitalization has increased by —, changing from – to – as of –.
In the year 2025, Co-Diagnostics’s market capitalization decreased from $24.80M in January to $8.12M in December, reflecting a -67.26% change.
In the past five years, Co-Diagnostics (CODX) has had a compound annual growth rate (CAGR) of -51.49% in market capitalization. This means its market cap has shrunk at an average rate of -51.49% per year.